1. Detection of H-ras Mutations in Urine Sediments by a Mutant-enriched PCR Technique
   José Ramón Conejo et al, 1998, Clinical Chemistry CrossRef
2. Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors
   D. Vageli et al, 1996, Cancer Letters CrossRef
3. Detection of DNA Methylation Changes in Body Fluids
   Triantafillos Liloglou et al, 2010, Epigenetics and Cancer, Part B CrossRef
4. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine
   Kazuhiro Yoshida et al, 1997, Cancer CrossRef
5. Prognostic significance of oncogenes and tumor suppressor genes in human malignancy
   D. A. Spandidos et al, 1993, STEM CELLS CrossRef
6. Recent advances in the study of tumour invasion and metastasis.
   D Tarin et al, 1994, Journal of Clinical Pathology CrossRef
7. Current understanding of the biology of advanced bladder cancer
   Sana Al-Sukhun et al, 2003, Cancer CrossRef
8. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer
   Satoshi Sugita et al, 2018, International Journal of Oncology CrossRef
9. Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancy
   David Tarin et al, 1993, Journal of Cellular Biochemistry CrossRef
10. Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene.
    K Yoshida et al, 1996, Journal of Clinical Pathology CrossRef
11. H-RAS, K-RAS, and N-RAS Gene Activation in Human Bladder Cancers
    B Przybojewska et al, 2000, Cancer Genetics and Cytogenetics CrossRef
12. Molecular markers in bladder cancer: A critical appraisal
    Badrinath R. Konety, 2006, Urologic Oncology: Seminars and Original Investigations CrossRef
13. Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets
    Hashim Uddin Ahmed et al, 2005, Expert Review of Anticancer Therapy CrossRef
14. Molecular biology of transitional cell carcinoma
    Sana Al-Sukhun et al, 2003, Critical Reviews in Oncology/Hematology CrossRef
15. Activation of RAS Family Genes in Urothelial Carcinoma
    I. Boulalas et al, 2009, Journal of Urology CrossRef
16. Mutational analysis ofRashotspots in patients with urothelial carcinoma of the bladder
    Kiran Tripathi et al, 2020, World Journal of Clinical Oncology CrossRef